Pub. Date : 1987 Dec 15
PMID : 3677090
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Since estrogen is a well documented mitogen of estrogen-responsive human breast cancer (HBC) cells, we studied the influence of estradiol and its antagonist tamoxifen on the expression of c-myc in HBC cell lines. | Tamoxifen | MYC proto-oncogene, bHLH transcription factor | Homo sapiens |
2 | In the ER+ cell lines the addition of estradiol resulted in a noticeable increase in c-myc expression after 15 min with a maximal (greater than 10-fold) induction in 1-2 h. In the ER- cell lines the level of c-myc mRNA was high and was unaffected by estrogen or tamoxifen; in the ER- cancer cell lines, neither amplification nor rearrangement of the c-myc gene was observed. | Tamoxifen | MYC proto-oncogene, bHLH transcription factor | Homo sapiens |
3 | In the ER+ cell lines the addition of estradiol resulted in a noticeable increase in c-myc expression after 15 min with a maximal (greater than 10-fold) induction in 1-2 h. In the ER- cell lines the level of c-myc mRNA was high and was unaffected by estrogen or tamoxifen; in the ER- cancer cell lines, neither amplification nor rearrangement of the c-myc gene was observed. | Tamoxifen | MYC proto-oncogene, bHLH transcription factor | Homo sapiens |
4 | In the ER+ cell lines the addition of estradiol resulted in a noticeable increase in c-myc expression after 15 min with a maximal (greater than 10-fold) induction in 1-2 h. In the ER- cell lines the level of c-myc mRNA was high and was unaffected by estrogen or tamoxifen; in the ER- cancer cell lines, neither amplification nor rearrangement of the c-myc gene was observed. | Tamoxifen | MYC proto-oncogene, bHLH transcription factor | Homo sapiens |